rs652572
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.3949+48T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 1,504,160 control chromosomes in the GnomAD database, including 314,793 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.59 ( 27238 hom., cov: 31)
Exomes 𝑓: 0.65 ( 287555 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0210
Publications
11 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110167110-A-G is Benign according to our data. Variant chr13-110167110-A-G is described in ClinVar as Benign. ClinVar VariationId is 1269926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A1 | NM_001845.6 | c.3949+48T>C | intron_variant | Intron 44 of 51 | ENST00000375820.10 | NP_001836.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.588 AC: 89047AN: 151432Hom.: 27237 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
89047
AN:
151432
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.651 AC: 163568AN: 251176 AF XY: 0.653 show subpopulations
GnomAD2 exomes
AF:
AC:
163568
AN:
251176
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.649 AC: 878332AN: 1352608Hom.: 287555 Cov.: 21 AF XY: 0.650 AC XY: 441522AN XY: 679188 show subpopulations
GnomAD4 exome
AF:
AC:
878332
AN:
1352608
Hom.:
Cov.:
21
AF XY:
AC XY:
441522
AN XY:
679188
show subpopulations
African (AFR)
AF:
AC:
12118
AN:
31436
American (AMR)
AF:
AC:
31624
AN:
44566
Ashkenazi Jewish (ASJ)
AF:
AC:
15287
AN:
25468
East Asian (EAS)
AF:
AC:
25426
AN:
39174
South Asian (SAS)
AF:
AC:
55411
AN:
84020
European-Finnish (FIN)
AF:
AC:
38889
AN:
53286
Middle Eastern (MID)
AF:
AC:
3066
AN:
5322
European-Non Finnish (NFE)
AF:
AC:
660042
AN:
1012550
Other (OTH)
AF:
AC:
36469
AN:
56786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
16041
32083
48124
64166
80207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16574
33148
49722
66296
82870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.588 AC: 89085AN: 151552Hom.: 27238 Cov.: 31 AF XY: 0.595 AC XY: 44049AN XY: 74078 show subpopulations
GnomAD4 genome
AF:
AC:
89085
AN:
151552
Hom.:
Cov.:
31
AF XY:
AC XY:
44049
AN XY:
74078
show subpopulations
African (AFR)
AF:
AC:
16538
AN:
41338
American (AMR)
AF:
AC:
10070
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
AC:
2065
AN:
3468
East Asian (EAS)
AF:
AC:
3340
AN:
5110
South Asian (SAS)
AF:
AC:
3263
AN:
4804
European-Finnish (FIN)
AF:
AC:
7590
AN:
10496
Middle Eastern (MID)
AF:
AC:
175
AN:
290
European-Non Finnish (NFE)
AF:
AC:
44387
AN:
67792
Other (OTH)
AF:
AC:
1247
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1771
3543
5314
7086
8857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
756
1512
2268
3024
3780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2374
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.